BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29661690)

  • 1. The History of Testosterone and the Evolution of its Therapeutic Potential.
    Morgentaler A; Traish A
    Sex Med Rev; 2020 Apr; 8(2):286-296. PubMed ID: 29661690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new era of testosterone and prostate cancer: from physiology to clinical implications.
    Khera M; Crawford D; Morales A; Salonia A; Morgentaler A
    Eur Urol; 2014 Jan; 65(1):115-23. PubMed ID: 24011426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and prostate cancer: revisiting old paradigms.
    Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
    Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.
    Morgentaler A; Traish A; Hackett G; Jones TH; Ramasamy R
    Sex Med Rev; 2019 Oct; 7(4):636-649. PubMed ID: 31351915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone Therapy and Prostate Cancer.
    Davidson E; Morgentaler A
    Urol Clin North Am; 2016 May; 43(2):209-16. PubMed ID: 27132578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is testosterone a friend or a foe of the prostate?
    Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
    J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone Therapy in Men With Prostate Cancer.
    Kaplan AL; Hu JC; Morgentaler A; Mulhall JP; Schulman CC; Montorsi F
    Eur Urol; 2016 May; 69(5):894-903. PubMed ID: 26719015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of testosterone therapy in men with prostate cancer.
    Morgentaler A; Caliber M
    Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.
    Traish AM
    Sex Med Rev; 2018 Jan; 6(1):86-105. PubMed ID: 29128268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guilt by association: a historical perspective on Huggins, testosterone therapy, and prostate cancer.
    Morgentaler A
    J Sex Med; 2008 Aug; 5(8):1834-40. PubMed ID: 18547385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth.
    Krakowsky Y; Morgentaler A
    Eur Urol Focus; 2019 Jan; 5(1):81-89. PubMed ID: 28753828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long and tortuous history of the discovery of testosterone and its clinical application.
    Morales A
    J Sex Med; 2013 Apr; 10(4):1178-83. PubMed ID: 23360502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy in prostate cancer: is it still a controversy?
    Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
    Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone Therapy Among Prostate Cancer Survivors.
    Nguyen TM; Pastuszak AW
    Sex Med Rev; 2016 Oct; 4(4):376-88. PubMed ID: 27474995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in Testosterone Therapy.
    Twitchell DK; Pastuszak AW; Khera M
    Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSMĀ 2015).
    Khera M; Adaikan G; Buvat J; Carrier S; El-Meliegy A; Hatzimouratidis K; McCullough A; Morgentaler A; Torres LO; Salonia A
    J Sex Med; 2016 Dec; 13(12):1787-1804. PubMed ID: 27914560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate carcinoma and testosterone: risks and controversies].
    Rhoden EL; Averbeck MA
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.
    Kim JW
    Investig Clin Urol; 2020 May; 61(3):242-249. PubMed ID: 32377599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
    Morgentaler A
    J Urol; 2009 Mar; 181(3):972-9. PubMed ID: 19150547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.